Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
CALL
Alphatec Holdings
ATEC
$1.47B
| $9.75M | 0.01% |
+800,000
| New | +$11.2M |
|
|
LCAA
2052
DELISTED
L Catterton Asia Acquisition Corp Class A Ordinary Shares
LCAA
| $9.75M | 0.01% |
1,002,061
+703,688
| +236% | +$6.83M |
|
|
FPAC
2053
DELISTED
Far Peak Acquisition Corporation
FPAC
| $9.75M | 0.01% |
979,520
+940,646
| +2,420% | +$9.36M |
|
2054
PUT
MSCI
MSCI
$42B
| $9.73M | 0.01% |
16,000
+14,700
| +1,131% | +$8.98M |
|
|
TRIL
2055
DELISTED
Trillium Therapeutics Inc.
TRIL
| $9.73M | 0.01% |
553,684
+345,612
| +166% | +$4.04M |
|
2056
AlTi Global
ALTI
$396M
| $9.73M | 0.01% |
987,798
+449,791
| +84% | +$4.37M |
|
|
EB
2057
DELISTED
Eventbrite
EB
| $9.72M | 0.01% |
514,303
-871,836
| -63% | -$15.3M |
|
|
RADI
2058
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
| $9.72M | 0.01% |
595,376
+541,308
| +1,001% | +$8.7M |
|
2059
PUT
Prudential Financial
PRU
$42.6B
| $9.72M | 0.01% |
92,400
-6,200
| -6% | -$639K |
|
2060
Ultragenyx Pharmaceutical
RARE
$2.43B
| $9.72M | 0.01% |
107,764
-455,623
| -81% | -$41.2M |
|
|
AAWW
2061
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $9.72M | 0.01% |
118,970
-5,330
| -4% | -$384K |
|
|
EAR
2062
DELISTED
Eargo, Inc. Common Stock
EAR
| $9.7M | 0.01% |
72,063
+19,038
| +36% | +$10.2M |
|
2063
PUT
Axsome Therapeutics
AXSM
$11.3B
| $9.69M | 0.01% |
+293,900
| New | +$11.5M |
|
2064
Envoy Medical
COCH
$51.6M
| $9.67M | 0.01% |
996,037
+15,396
| +2% | +$149K |
|
|
ACRE
2065
Ares Commercial Real Estate
ACRE
$231M
| $9.67M | 0.01% |
641,320
-239,328
| -27% | -$3.63M |
|
|
SWAGU
2066
DELISTED
Software Acquisition Group Inc. III Unit
SWAGU
| $9.66M | 0.01% |
+956,529
| New | +$9.61M |
|
2067
CALL
NeoGenomics
NEO
$2.02B
| $9.65M | 0.01% |
+200,000
| New | +$9.26M |
|
|
TWTR
2068
DELISTED
Twitter, Inc.
TWTR
| $9.65M | 0.01% |
159,763
-482,300
| -75% | -$31.7M |
|
2069
CALL
Renaissance IPO ETF
IPO
$153M
| $9.65M | 0.01% |
+150,000
| New | +$9.77M |
|
|
2070
PUT
Renaissance IPO ETF
IPO
$153M
| $9.65M | 0.01% |
+150,000
| New | +$9.77M |
|
2071
Sabre
SABR
$719M
| $9.64M | 0.01% |
813,913
+766,971
| +1,634% | +$8.7M |
|
2072
CALL
iShares Core Dividend Growth ETF
DGRO
$42.7B
| $9.64M | 0.01% |
191,800
+91,800
| +92% | +$4.75M |
|
2073
GoPro
GPRO
$120M
| $9.63M | 0.01% |
1,029,316
-794,680
| -44% | -$8.03M |
|
2074
CBIZ
CBZ
$2.99B
| $9.63M | 0.01% |
297,877
+242,013
| +433% | +$7.88M |
|
|
BRDG
2075
DELISTED
Bridge Investment Group
BRDG
| $9.63M | 0.01% |
+544,887
| New | +$9.39M |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.